Home >> Business >> Human Microbiome Market 2018-2026 | Size, Share, Opportunities and Forecast | Credence Research

Human Microbiome Market 2018-2026 | Size, Share, Opportunities and Forecast | Credence Research

The latest market report published by Acute Market Reports, Inc. “Global Human Microbiome Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global human microbiome market was valued at US$ 840.1 million in 2017 and is expected to hit US$ 1990.5 million by 2026, expanding at a CAGR of 10.1 percent from 2018 to 2026.

Market Insights
Human microbiome refers to the good and healthy microbes present in the gastrointestinal tract of humans. The primary function of these microbes is to assist in the absorption of digestion and synthesis of essential nutrients for the human body. The importance of microorganism in maintaining healthy human homeostasis has been known and studied for centuries. The human microbiome market is driven by factors such as the rising prevalence of chronic diseases and technological development in the nutraceutical industry focusing primarily on prebiotics and probiotics market growth. The importance of human microbiome in developing as a diagnostic tool is still in its infancy with regulatory approval challenges.

Don’t miss out on business opportunities in Human Microbiome Market.

Contact Us For Customization in Type, Application & Region: https://www.acutemarketreports.com/inquiry-before-buying/59376

Prebiotics and probiotics occupy the largest share in the products segment owing to its importance in maintaining healthy gut microflora which aids the synthesis of essential amino acids, small chain fatty acids and absorption of vitamins. The source for probiotics and prebiotics is abundant ranging from dairy, cereals, vegetable, and fruits. State of the art formulation and development segment present in the nutraceutical industry makes it available in a diverse range of products for all age group. Supplements are gaining prominence as adjuvant and supportive therapy for the treatment of lifestyle disorders such as diabetes, cardiovascular diseases, gastrointestinal disorders, etc.

Currently, therapeutics dominate the application segment due to key factors such as increasing public demand for probiotics and prebiotics to maintain excellent gastrointestinal health. Exhaustive research in identifying the useful microbes in the gut flora and their availability as probiotics and dietary supplements has resulted in positive traction for the therapeutic segment. The human microbiome is gaining a promising future as a diagnostic tool for detecting chronic infectious diseases such as cholera, diarrhea, gastroenteritis, etc.

According to statistics from the Center for Disease Control and Prevention (CDC) in 2016, about 14.7 million people in the United States were diagnosed with gastrointestinal ulcers. The growth of the human microbiome market in North America is determined by increasing the prevalence of chronic diseases and increasing public health awareness of healthy dietary intake. The European Center for Disease Control and Prevention (ECDC) has a prevalence rate of 20.7% of functional gastrointestinal disorders in adolescents in the Mediterranean region of Europe. The home of major players and the development of healthcare infrastructure are driving the human microbiome market in Europe. Local players emerging in the Asia Pacific as imposed fierce competition on market leaders providing human microbiome products. It serves as a lucrative market for medical food and dietary supplements to strengthen infant nutrition and health.

The pioneering companies providing human microbiome products are DuPont, Enterome Bioscience, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Synthetic Biologics, Inc., Synlogic, Inc., Vedanta Biosciences, Inc., Vithera Pharmaceuticals and Yakult Honsha Co., Ltd.

Key Market Movements:

The increasing number of patients suffering from chronic diseases and rising public health awareness
Increased research activities in identifying the therapeutic efficacy of microbes and developing them as probiotics
Rise in per capita income in developing nations which has built positive traction in the purchase of medical foods and supplements

Get Sample (Free) @ https://www.acutemarketreports.com/sample-request/59376

ToC:
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
……………
Chapter 3. Human Microbiome Market: Dynamics and Future Outlook
…………….
Chapter 4. Global Human Microbiome Market, by Product
4.1. Overview
4.2. Probiotics
4.3. Prebiotics
4.4. Medical Foods
4.5. Supplements
4.6. Others

Chapter 5. Global Human Microbiome Market, by Application
5.1. Overview
5.2. Diagnostics
5.3. Therapeutics

Chapter 6. Global Human Microbiome Market, by Geography
………………..
Chapter 7. Company Profiles
7.1. DuPont
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Enterome Bioscience
7.3. Osel, Inc.
7.4. Second Genome, Inc.
7.5. Seres Therapeutics
7.6. Synthetic Biologics, Inc.
7.7. Synlogic, Inc.
7.8. Vedanta Biosciences, Inc.
7.9. Vithera Pharmaceuticals
7.10. Yakult Honsha Co., Ltd.
……………………….toc continued

Browse the full report Human Microbiome Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.acutemarketreports.com/report/human-microbiome-market

Research methodology applied for this study:

Methodology of this research study includes primary and secondary research for defining the market size, shares and forecast for global Human Microbiome market specific to key segments, and regional segmentation.

a.            Secondary Research

Secondary research was initiated with data collected through sources such as press releases, company annual reports, and relevant documents focusing on the current developments in the global Human Microbiome market. Authentic sources such as university research papers, scientific journals, and government websites were similarly screened for identifying business opportunities in several geographical markets and penetration of various products/services in these geographies. Paid databases were excavated to assemble information beneficial for broad commercial study of the key players operating in Human Microbiome market. In case lack of data availability on the public domain, we used estimation models to arrive at comprehensive data sets. Secondary research helped to create a firm base to build market size, analyze trends, and understand the dynamics of Human Microbiome market study.

b.            Primary Research

The exhaustive secondary research practiced was supported & validated by extensive primary research. Primary research was carried out with the help of e-mail interactions, telephonic interviews, as well as face-to-face interviews with the leading industry stakeholders.

The participants tracked for primary interviews include:

•             Marketing/product managers

•             Vice President/ CEOs

•             National sales managers

•             Market intelligence managers

•             Distributors

•             Purchasing managers

•             Other stakeholders

About Us:
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Leave a Reply

Your email address will not be published. Required fields are marked *